Palvella Therapeutics (PVLA) Misses Q2 EPS by 36c

Palvella Therapeutics (NASDAQ: PVLA) reported Q2 EPS of ($1.52), $0.36 worse than the analyst estimate of ($1.16).

For earnings history and earnings-related data on Palvella Therapeutics (PVLA) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• Goldman Sachs Downgrades Schindler Holding AG (SCHN:SW) (SHLAF) to Sell
• ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs